Status:
COMPLETED
Hypothyroidism Treated With Calcitonin
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Hypothyroidism
Eligibility:
All Genders
18-88 years
Phase:
PHASE4
Brief Summary
Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.
Detailed Description
It is known that a proportion of patients with hypothyroidism despite serum TSH levels being within the normal reference range, may continue to express symptoms of hypothyroidism. Common symptoms incl...
Eligibility Criteria
Inclusion
- Normal TSH on levothyroxine therapy
Exclusion
- pregnant or 6 months post partum
- Current or previous thyroid cancer
- Congenital hypothyroidism
- any tobacco use
- prescribed proton pump inhibitors
- prescribed steroids
- taking armour thyroid, naturethroid, or any dessicated thyroid hormone
- Unstable medical conditions (CKD, Cirrhosis etc)
- pituitary disease
Key Trial Info
Start Date :
June 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2019
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03342001
Start Date
June 18 2018
End Date
August 14 2019
Last Update
February 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Center for Diabetes and Endocrinology
Baltimore, Maryland, United States, 21201